Health & Biotech
Singular Health is a Western Australian, ASX-listed (ASX: SHG) medical technology company on a mission to create a seamless and integrated healthcare ecosystem where the full value of medical imaging records is unlocked, enabling universal access and promoting interoperability to maximise patient outcomes.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Singular Health pulling out all the stops to make first US sale
Health & Biotech
ASX Biotech Stocks: Clover can boost premature kids IQs, First Graphene nabs US patent for supercapacitor tech
News
ASX Small Caps Lunch Wrap: Who else is battling IT issues today?
Health & Biotech
Singular Health’s 3Dicom FDA submission could open door to US$885.2m medical imaging software market
News
Rise and Shine: Everything you need to know before the ASX opens
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Leading Aussie medtechs Osteopore and Singular Health reveal landmark deal
News
Closing Bell: Resources reboot puts fresh socks on small cap index
News
Closing Bell: Sinking local markets jump ship as Central Bank prepares to board
Health & Biotech
Singular’s additive manufacturing investment is bearing fruit
Health & Biotech
Singular’s AI-based cranial implant gets a partner to dream of in Osteopore
Health & Biotech
ASX Health Stocks: US FDA approval could expand EBR Systems’ addressable market by $400m
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Singular enters giant East Asia medical VR market with breakthrough Macau JV
Health & Biotech
Government backs Singular Health innovation with $305k R&D tax fund
Health & Biotech
RedLeaf: Singular has a sweet slice of the global VR, AI medical imaging pie
Experts